G

EX-99.1

2 genpactltdexhibit991q126.htm

EX-99.1

Document

Exhibit 99.1

Genpact Reports First Quarter 2026 Results

Advanced Technology Solutions net revenue growth accelerates to 24% year-over-year, now representing 27% of total net revenues

NEW YORK, May 7, 2026 — Genpact Limited (NYSE: G), an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence, and last-mile expertise, today announced financial results for the first quarter ended March 31, 2026.

“The first quarter was a record start to the year, with Advanced Technology Solutions net revenue growth accelerating to 24%, now representing 27% of total net revenues. We are leading the shift to Agentic Operations and winning,” said Balkrishan “BK” Kalra, President and CEO, Genpact. “Clients choose Genpact because agentic transformation only succeeds when it's grounded in real-world expertise. It's our decades of last-mile domain and process knowledge, codified and embedded into every agentic solution, that turns ambition into outcomes. A new Genpact is taking shape, and our results speak for themselves.”

“We delivered another strong quarter — with net revenues up 6.7%, diluted earnings per share up 17.8% and adjusted diluted earnings per share1 increasing 16.7% year-over-year. Q1’26 marks our 12th consecutive quarter of gross margin expansion year-over-year, clearly demonstrating that our operational discipline and deliberate pivot to high-value advanced technology revenue are compounding into durable, structural gains,” said Michael Weiner, Chief Financial Officer, Genpact. “With our significant momentum and growing demand, we are in a strong position for the remainder of the year.”

Key Financial Highlights – First Quarter 2026

•Net revenues were $1.296 billion, up 6.7% year-over-year, and 5.6% on a constant currency basis.2

◦Advanced Technology Solutions net revenues were $345 million, up 24.3% year-over-year, representing 27% of total net revenues.

◦Core Business Services net revenues were $951 million, up 1.4% year-over-year, representing 73% of total net revenues.

•Gross profit was $472 million, up 9.9% year-over-year, with a corresponding margin of 36.4%.

•Net income was $148 million, up 13.1% year-over-year, with a corresponding margin of 11.4%.

•Income from operations was $199 million, up 8.1% year-over-year, with a corresponding margin of 15.3%.

•Adjusted income from operations was $224 million, up 6.6% year-over-year, with a corresponding margin of 17.3%.3

•Diluted earnings per share was $0.86, up 17.8% year-over-year.

1 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.

2 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period.

3 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income to adjusted income from operations and GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin are attached to this release.

•Adjusted diluted earnings per share1 was $0.98, up 16.7% year-over-year.

•Cash utilized in operations was $24 million, compared to $40 million generated from operations in the first quarter of 2025.

•Genpact repurchased approximately 1.8 million common shares during the quarter for total consideration of approximately $70 million at an average price per share of $38.61.

Outlook

Genpact's outlook for the second quarter of 2026 is as follows:

•Net revenues in the range of $1.324 billion to $1.336 billion, representing year-over-year growth of approximately 5.5% to 6.5% as reported, or 5.4% to 6.4% on a constant currency basis.2

◦In Advanced Technology Solutions, we expect revenue to grow at least 20%.

◦In Core Business Services, we expect growth to continue.

•Gross margin of approximately 36.4%.

•Adjusted income from operations margin4 of approximately 17.4%.

•Adjusted diluted earnings per share5 in the range of $0.96 to $0.97.

Genpact's outlook for the full year 2026 is as follows:

•Net revenue growth of at least 7% on an as reported basis, or 6.8% on a constant currency basis.2

◦In Advanced Technology Solutions, we now expect revenue to grow at least 20%.

◦In Core Business Services, we expect growth to continue.

•Gross margin of approximately 36.5%, up approximately 50 basis points year-over-year.

•Adjusted income from operations margin4 of approximately 17.7%, up approximately 25 basis points year-over-year.

•Adjusted diluted earnings per share5 growth of more than 10%.

First Quarter 2026 Earnings Call

Genpact's management will host a conference call on May 7, 2026, at 5:00PM ET to dis

g-202602050001398659FALSE00013986592026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda     001-3362698-0533350 (State or other jurisdiction of incorporation)   (Commission File Number)(I.R.S. Employer Identification No.)

Canon's Court, 22 Victoria Street Hamilton HM 12, Bermuda (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (441) 298-3300 Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Common shares, par value $0.01 per shareGNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02Results of Operations and Financial Condition. On February 5, 2026, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months and full year ended December 31, 2025.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.Financial Statements and Exhibits. (d)Exhibits:

Exhibit 99.1  Press release dated February 5, 2026

Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENPACT LIMITED

Date: February 5, 2026 By: /s/ Michael Weiner Name: Michael Weiner Title: Senior Vice President, Chief Financial Officer

g-202511060001398659FALSE00013986592025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda     001-3362698-0533350 (State or other jurisdiction of incorporation)   (Commission File Number)(I.R.S. Employer Identification No.)

Canon's Court, 22 Victoria Street Hamilton HM 12, Bermuda (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (441) 298-3300 Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Common shares, par value $0.01 per shareGNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02Results of Operations and Financial Condition. On November 6, 2025, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months ended September 30, 2025.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.Financial Statements and Exhibits. (d)Exhibits:

Exhibit 99.1  Press release dated November 6, 2025

Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENPACT LIMITED

Date: November 6, 2025 By: /s/ Heather D. White Name: Heather D. White Title: Senior Vice President, Chief Legal Officer and Secretary